|By PR Newswire||
|January 28, 2014 06:40 PM EST||
DUBLIN, Ireland, January 28, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/fvxjv3/cardiovascular) has announced the addition of a new report "Global Cardiovascular Drug Delivery Market" to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to all organs of the body. Drugs can be introduced into the vascular system for systemic effects or targeted to an organ via the regional blood supply. In addition to the usual formulations of drugs such as controlled release, devices are used as well. This report starts with an introduction to molecular cardiology and discusses its relationship to biotechnology and drug delivery systems.
Drug delivery to the cardiovascular system is approached at three levels: (1) routes of drug delivery; (2) formulations; and finally (3) applications to various diseases. Formulations for drug delivery to the cardiovascular system range from controlled release preparations to delivery of proteins and peptides. Cell and gene therapies, including antisense and RNA interference, are described in full chapters as they are the most innovative methods of delivery of therapeutics. Various methods of improving systemic administration of drugs for cardiovascular disorders are described including use of nanotechnology.
Cell-selective targeted drug delivery has emerged as one of the most significant areas of biomedical engineering research, to optimize the therapeutic efficacy of a drug by strictly localizing its pharmacological activity to a pathophysiologically relevant tissue system. These concepts have been applied to targeted drug delivery to the cardiovascular system. Devices for drug delivery to the cardiovascular system are also described.
Role of drug delivery in various cardiovascular disorders such as myocardial ischemia, hypertension and hypercholesterolemia is discussed. Cardioprotection is also discussed. Some of the preparations and technologies are also applicable to peripheral arterial diseases. Controlled release systems are based on chronopharmacology, which deals with the effects of circadian biological rhythms on drug actions.A full chapter is devoted to drug-eluting stents as treatment for restenosis following stenting of coronary arteries.Fifteen companies are involved in drug-eluting stents.
New cell-based therapeutic strategies are being developed in response to the shortcomings of available treatments for heart disease. Potential repair by cell grafting or mobilizing endogenous cells holds particular attraction in heart disease, where the meager capacity for cardiomyocyte proliferation likely contributes to the irreversibility of heart failure. Cell therapy approaches include attempts to reinitiate cardiomyocyte proliferation in the adult, conversion of fibroblasts to contractile myocytes, conversion of bone marrow stem cells into cardiomyocytes, and transplantation of myocytes or other cells into injured myocardium.
Advances in molecular pathophysiology of cardiovascular diseases have brought gene therapy within the realm of possibility as a novel approach to treatment of these diseases. It is hoped that gene therapy will be less expensive and affordable because the techniques involved are simpler than those involved in cardiac bypass surgery, heart transplantation and stent implantation.
Key Topics Covered:
1. Cardiovascular Diseases
2. Methods for Drug Delivery to the Cardiovascular System
3. Cell Therapy for Cardiovascular Disorders
4. Gene Therapy for Cardiovascular Disorders
5. Drug-Eluting Stents
6. Markets for Cardiovascular Drug Delivery
7. Companies involved in Cardiovascular Drug Delivery
For more information visit http://www.researchandmarkets.com/research/fvxjv3/cardiovascular
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
Aug. 25, 2016 04:15 PM EDT Reads: 337
Aug. 25, 2016 03:30 PM EDT Reads: 1,480
Aug. 25, 2016 03:15 PM EDT Reads: 2,196
Aug. 25, 2016 02:00 PM EDT Reads: 3,543
Aug. 25, 2016 01:45 PM EDT Reads: 1,356
Aug. 25, 2016 01:00 PM EDT Reads: 3,885
Aug. 25, 2016 01:00 PM EDT Reads: 2,590
Aug. 25, 2016 12:45 PM EDT Reads: 579
Aug. 25, 2016 12:45 PM EDT Reads: 570
Aug. 25, 2016 12:15 PM EDT Reads: 3,382
Aug. 25, 2016 11:00 AM EDT Reads: 534
Aug. 25, 2016 11:00 AM EDT Reads: 1,826
Aug. 25, 2016 10:30 AM EDT Reads: 486
Aug. 25, 2016 09:15 AM EDT Reads: 600
Aug. 25, 2016 09:00 AM EDT Reads: 496